ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

PALI vs DTIL // ALTMAN Z-SCORE & DEBT/EQUITY

Palisade Bio Inc. (NASDAQ) VS. Precision BioSciences Inc. (NASDAQ) • 15-METRIC TALLY: PALI 2 — DTIL 1
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PALI VS. DTIL) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC PALI DTIL SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield -5.23% — — TIE /fcf-yield <GO>
Operating Margin — -60.00% — TIE /operating-margins <GO>
Net Profit Margin — -60.00% — TIE /net-margins <GO>
Revenue Growth (YoY) — -50.10% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity ACTIVE — 0.20 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 2/9 1/9 +1.00 PALI /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 30.1 55.8 -25.68 DTIL /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $207.4M $205.4M $2.0M PALI /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR PALI REV DTIL REV PALI GROSS % DTIL GROSS % PALI FCF DTIL FCF
FY 2025 $0 $34.3M — — -$10.8M -$65.8M
FY 2024 $0 $68.7M — — -$12.2M -$58.4M
FY 2023 $250.0K $48.7M — — -$11.1M -$84.1M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PALI // BETA —
DTIL // BETA —